There is a need to innovate and think differently — what Queen Ulrika Eleonora did three centuries back in Sweden. It was her visionary thinking and leadership which led to improve maternal health. Today, Sweden maternal mortality is less than 5 per lakh live births. Learning a lesson from the past, we should do the following to ensure that no women should die giving a life. • Empower household and communities Although the government is trying to improve maternal health care and services under the National Health Mission Programme, there is need to accelerate these. Some of these are: • Ensure hundred percent institutional delivery by skilled attendant nurses or doctors at birth for all women. India

can reduce maternal death by Selinexor mw learning DNA Damage inhibitor lessons from the past and by improving maternal health care services, but it needs political and societal commitment. There is no conflict of interest. The author is thankful to Professor Jay Satia for the idea to develop this paper and Ms. Moi Lee Liow for her comments and suggestions. “
“Misoprostol is recommended by the Danish Association of Obstetricians and Gynecologists for induction of labor [1]. It is

used off-label as Cytotec®, a medication that is currently only registered as treatment of gastric ulcers. The authors of the two latest Cochrane meta-analyses on misoprostol-induced labor underline the lack of sufficient statistical power to measure rare and serious side effects. Thus, they call on readers to report incidents of uterine rupture [2] and [3]. We report a case that draws attention to these issues: 1) misoprostol even when used in small doses on an unscarred uterus Oxygenase might cause uterine rupture and 2) side effects in the setting of off-label use should be reported to national reporting systems, where such systems are available. A woman, who had delivered her first baby via uncomplicated vaginal delivery, is induced at 42 + 0 weeks of gestation due to routine procedure in a Danish hospital in 2009. Apart from the gestation her pregnancy is normal. The patient record does not reveal the Bishops Score, but her cervix is initially described as no

cervical dilatation, 2 cm in length, posterior location. At 11.53 am 25 μg misoprostol is placed in the posterior fornix of her vagina. Approximately 1 h later, at 1.00 pm after a normal CTG, she leaves the hospital according to hospital policy. She returns home to await contractions and does not receive further treatment with misoprostol. 7 h later, at eight o’clock pm she calls the hospital due to increasing labor pains. She is encouraged to stay at home. 10 min past midnight, 13 h after the misoprostol was inserted, she returns to the hospital now with strong contractions occurring every 2–3 min. She is 3–4 cm dilated, cervix is 1/2–1 cm, posterior location and soft with the fetal head present at the pelvic brim. She is in pain, and asks for an epidural block.